Insurance
Home›Insurance›Health Insurance›Accelerant’s $4bn sale puts specialty capacity terms u…
Accelerant’s $4bn sale puts specialty capacity terms under scrutiny
Thoma Bravo’s acquisition of a data-driven risk exchange raises questions about underwriting continuity for brokers
← Newer storyUS liability costs surge as claim severity outpaces inflationOlder story →US auto insurance data exposes a first-year retention gap
More like this
InsuranceLoti raises $3.35 million
InsuranceUSAA partners with LegalZoom
Sources
Insurance BusinessAccelerant’s $4bn sale puts specialty capacity terms under scrutiny